Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

Record identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ef3d2981a94245169b5609cd64e66c97

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ef3d2981a94245169b5609cd64e66c97

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

Full title

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in oncology, 2018, Vol.8, p.474-474

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ef3d2981a94245169b5609cd64e66c97

Language

English

Formats

Publication information

Publisher

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ef3d2981a94245169b5609cd64e66c97

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ef3d2981a94245169b5609cd64e66c97

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card